303 related articles for article (PubMed ID: 26332753)
1. Rapid ADAMTS13 availability impacts treatment for microangiopathic hemolytic anemia and thrombocytopenia.
Martin IW; Katus MC; Martin CL; Szczepiorkowski ZM; Gorham JD; Dunbar NM
J Clin Apher; 2016 Oct; 31(5):419-22. PubMed ID: 26332753
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
Scully M
Semin Thromb Hemost; 2016 Oct; 42(7):774-779. PubMed ID: 27648610
[TBL] [Abstract][Full Text] [Related]
3. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
Mehmood T; Taylor M; Winters JL
Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
[TBL] [Abstract][Full Text] [Related]
4. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis.
Masias C; Cataland SR
Blood; 2018 Aug; 132(9):903-910. PubMed ID: 30006329
[TBL] [Abstract][Full Text] [Related]
5. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
[TBL] [Abstract][Full Text] [Related]
6. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
7. Cocaine-induced microangiopathic hemolytic anemia mimicking idiopathic thrombotic thrombocytopenic purpura: a case report and review of the literature.
Odronic S; Quraishy N; Manroa P; Kier Y; Koo A; Figueroa P; Hamilton A
J Clin Apher; 2014 Oct; 29(5):284-9. PubMed ID: 24753113
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia.
Maloney N; Martin I; Szczepiorkowski ZM; Dunbar NM
J Clin Apher; 2018 Jun; 33(3):436-438. PubMed ID: 29270999
[TBL] [Abstract][Full Text] [Related]
9. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
12. Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura.
Roose E; Joly BS
Hamostaseologie; 2020 Aug; 40(3):322-336. PubMed ID: 32726827
[TBL] [Abstract][Full Text] [Related]
13. How we approach an acquired thrombotic thrombocytopenic purpura patient.
Raval JS; Mazepa MA; Brecher ME; Park YA
Transfusion; 2014 Oct; 54(10):2375-82. PubMed ID: 25070750
[TBL] [Abstract][Full Text] [Related]
14. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
Coppo P; Veyradier A
Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.
Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M;
Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.
Peedin AR; Park YA; Mazepa MA; Rollins-Raval MA; Brecher ME; Raval JS
Ther Apher Dial; 2018 Dec; 22(6):662-665. PubMed ID: 30178615
[TBL] [Abstract][Full Text] [Related]
17. Acute thrombotic thrombocytopenic purpura in Louisiana: Seasonal distribution and evaluation of an ADAMTS13 order screening protocol.
Simenson V; Burton J; Del Toro A; Alquist CR
J Clin Apher; 2020 Aug; 35(4):264-270. PubMed ID: 32408376
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and Management of Thrombotic Thrombocytopenic Purpura in the Emergency Department.
Long B; Bridwell RE; Manchanda S; Gottlieb M
J Emerg Med; 2021 Dec; 61(6):674-682. PubMed ID: 34518045
[TBL] [Abstract][Full Text] [Related]
19. Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
Kubo M; Matsumoto M
Int J Hematol; 2023 Mar; 117(3):331-340. PubMed ID: 36757521
[TBL] [Abstract][Full Text] [Related]
20. [New developments in treatment modalities of thrombotic thrombocytopenic purpura].
Matsumoto M
Rinsho Ketsueki; 2017; 58(10):2081-2086. PubMed ID: 28978852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
